BRCA2 and cancer: In a follow-up study devoted to target validation and further mechanistic insights into CuET effects [4], we explored the reported exceptional sensitivity to DSF of human cancer cell lines defective in BRCA1 or BRCA2 tumor suppressors, key components of the genome integrity maintenance machinery [4,5].